Device manufacturer, as written on reports
Abbott Diagnostics Scarborough: medical device reports filed with FDA
12,943 reports name it as the manufacturer of the device involved, 2019–2026.
- 12,943
- reports naming it as manufacturer
- 0.1% of all MAUDE reports
- 718
- reports, 12 months to August 2026
- 481 in the 12 months before
- 96.5%
- classified as malfunction
- 62.3% across all reports
- 0.1%
- classified as death, as reported
- 0.9% across all reports
12,943 medical device reports received by FDA give Abbott Diagnostics Scarborough as the manufacturer of the device involved, 0.1% of the MAUDE database, from June 2019 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
718 reports arrived in the 12 months to August 2026, up 49% from 481 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (96.5%), injury (3.5%) and death (0.1%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Id Now Covid-19 Assay | Reagents, 2019-novel coronavirus nucleic acid | 3,357 | 0 | 0% |
| Binaxnow Covid-19 Ag Card | Coronavirus antigen detection test system. | 2,048 | 0 | 0% |
| Binaxnow Covid-19 Ag Self Test 2ct | Coronavirus antigen detection test system. | 1,297 | 53 | 0.1% |
| Id Now Covid-19 | Reagents, 2019-novel coronavirus nucleic acid | 865 | 0 | 0.4% |
| DETERMINE HIV-1/2 Ag/Ab COMBO 25T | Test, hiv detection | 801 | 569 | 0% |
| ID NOW COVID-19 2.0 Test KIT 24T JAPAN | Reagents, 2019-novel coronavirus nucleic acid | 704 | 37 | 0% |
| Binaxnow Covid-19 Antigen Self Test | Coronavirus antigen detection test system. | 595 | 0 | 0% |
| Id Now Covid 19 Assay | Reagents, 2019-novel coronavirus nucleic acid | 523 | 0 | 0% |
| Id Now Covid-19 2 0 Test Kit 24t Ous | Reagents, 2019-novel coronavirus nucleic acid | 489 | 0 | 0% |
| Binaxnow Covid-19 Antigen Self-Test | Coronavirus antigen detection test system. | 461 | 0 | 0% |
| Binax Now Covid-19 Ag Card | Coronavirus antigen detection test system. | 421 | 0 | 0% |
| Id Now Covid-19 2 0 Test Kit 24t Eua | Reagents, 2019-novel coronavirus nucleic acid | 158 | 12 | 0% |
| Alere Determine Hiv-1/2 Ag/Ab Combo | Test, hiv detection | 63 | 0 | 0% |
| Alere Determine Hiv 1/2 Ag/Ab Combo | Test, hiv detection | 6 | 0 | 0.2% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| QJR | Reagents, 2019-novel coronavirus nucleic acid | 6,233 | 48.2% |
| QKP | Coronavirus antigen detection test system. | 5,437 | 42% |
| MZF | Test, hiv detection | 997 | 7.7% |
| OOI | Real time nucleic acid amplification system | 45 | 0.3% |
| OCC | Respiratory virus panel nucleic acid assay system | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Abbott Diagnostics Scarborough reports
How many FDA device reports name Abbott Diagnostics Scarborough as manufacturer?
12,943 reports through August 2026, 718 of them in the latest 12 months.
Which of its brands appear most often?
Id Now Covid-19 Assay (3,357), Binaxnow Covid-19 Ag Card (2,048), Binaxnow Covid-19 Ag Self Test 2ct (1,297), Id Now Covid-19 (865) and DETERMINE HIV-1/2 Ag/Ab COMBO 25T (801).
Which device types does it report on?
reagents, 2019-novel coronavirus nucleic acid (48.2%), coronavirus antigen detection test system. (42%), test, hiv detection (7.7%) and real time nucleic acid amplification system (0.3%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.